Stock down over 50 percent YTD and this kind of posting over a .02 cent rise in price is comical. Company has done nothing but miss deadlines and fail to deliver and the 63 percent decline in price over the last 6 months shows that’s how the market feels. Trial has been going since August 7 2020 and still not up to 800 patients enrolled during a pandemic is FAILURE.
Market Data 
Markets 
AI
